Besides, Xu et al. bound nano-diamond doxorubicin conjugate (Nano-DOX) to a PD-L1 blocking agent named BMS-1, which can effectively reactivate the M1-type macrophages to kill tumor cells and inhibit tumor growth (Xu et al., 2021). The gene discussed is CD274; the disease is neoplasm.